BBLG Bone Biologics Corporation

NASDAQ
$0.50

Bone Biologics Corporation (BBLG) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.19 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -24.9% since its last earnings release on August 14, 2026.

Bone Biologics Missed Consensus Estimates
Friday, August 14, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · Before Open
Earnings Whisper
-
vs ($0.19)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.55

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Bone Biologics Corporation

Bone Biologics Corp. is a developer of orthobiologic products for spine fusion markets. Bone Biologics Corp. is based in BURLINGTON, Mass.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.